Fig. 2From: Earth-friendly-assessed silver-nanoparticles spectrophotometric method for rapid and sensitive analysis of Molnupiravir, an FDA-approved candidate for COVID-19: application on pharmaceutical formulation and dissolution testGreenness assessment profiles using the GAPI tool for a the proposed Ag–NPs method and b the reported LC method during the determination of MolnupiravirBack to article page